ArticleACS medicinal chemistry letters2022

Novel Macrocyclic Peptidylarginine Deiminase Type 4 (PAD4) Inhibitors.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.